Details

Autor(en) / Beteiligte

• Chen, Zhaoqiang
• Zhang, Zepeng
• Liu, Jiaqi
• Qi, Hongyu
• Li, Jing
• Chen, Jinjin
• Huang, Qingxia
• Liu, Qing
• Mi, Jia
• Li, Xiangyan

Titel

Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation

Ist Teil von

• Frontiers in cellular and infection microbiology, 2022-04, Vol.12, p.853981-853981

Ort / Verlag

Switzerland: Frontiers Media S.A

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Panax ginseng, as the king of Chinese herb, has significant therapeutic effects on obesity, type 2 diabetes mellitus, fatty liver disease, colitis, diarrhea, and many other diseases. This review systematically summarized recent findings, which show that ginseng plays its role by regulating gut microbiota diversity, and gut microbiota could also regulate the transformation of ginsenosides. We conclude the characteristics of ginseng in regulating gut microbiota, as the potential targets to prevent and treat metabolic diseases, colitis, neurological diseases, cancer, and other diseases. Ginseng treatment can increase some probiotics such as , , , , and reduce pathogenic bacteria such as , , against various diseases. Meanwhile, , , and were found to be the key bacteria for ginsenoside transformation . Overall, ginseng can regulate gut microbiome diversity, further affect the synthesis of secondary metabolites, as well as promote the transformation of ginsenosides for improving the absorptivity of ginsenosides. This review can provide better insight into the interaction of ginseng with gut microbiota in multiple disorders and ginsenoside transformation.